Long-term Clinical Outcomes and Predictors of Type-III Endoleak in a Large Cohort of Patients Treated With Anatomically Fixed Stent Grafts Over 20 Years

Abstract

Objective:

To assess the incidence, outcomes, and predictors of type III endoleaks (TIIIELs) in patients treated with different generations of Endologix unibody devices for abdominal aortic aneurysm (AAA).

Methods:

Patients treated with unibody endografts between 1999 and 2020 in a single unit were prospectively enrolled, retrospectively analyzed, and stratified according to device generation. The primary outcome was the incidence of TIIIEL in patients treated with unibody devices. Secondary outcomes included: (1) TIIIEL incidence among the different device generations; (2) comparison of type IIIa (TIIIaELs) and type IIIb endoleaks (TIIIbELs) incidence, treatment, and complications; (3) risk factor analysis for TIIIEL; (4) overall survival and survival free from TIIIEL.

Results:

A total of 872 patients who underwent endovascular aortic repair (EVAR) were analyzed. The cumulative incidence of TIIIEL was 4.8% (42/872). The incidence among different generations was 2.4% (10/414), 21.7% (15/69), and 4.6% (16/341), and 2.1% (1/48) for Powerlink, AFXs, AFXd, and AFX2. Freedom from TIIIEL by device generation was significantly lower in the AFXs group (p<0.001). Type III endoleaks was higher in urgent EVAR (p=0.011), large AAA (p<0.001), angulated and calcified necks (p=0.002), and when more than one modular component or non-proprietary extension was used (p<0.001). AFXs was found as independent risk factor for TIIIEL (hazard ratio [HR]=3.1, p=0.003), while the use of a single component decreased the risk (HR=0.3, p=0.005). Finally, every 10-mm increase in AAA diameter resulted in a 2-fold increase in TIIIEL risk (HR=2.0, p<0.001).

Conclusion:

The first generation of AFX endograft was associated with an increase in TIIIEL risk by 3.1 times, claiming a strict and careful follow-up in patients implanted with this device.

Clinical Impact

The old-generation of unibody endograft AFXs was associated with an increase in TIIIEL risk by 3.1 times. Angulated and calcified neck, large aneurysms and the use of nonproprietary graft extension were found as independent risk factors for TIIIEL. Patients implanted with these devices and with these anatomical features should be intensively monitored during follow-up.

Keywords

EVAR AAA endoleak TIIIEL AFX Endologix

Get full access to this article

View all access options for this article.

References

Parodi

Palmaz

Barone

HD.

Transfemoral intraluminal graft implantation for abdominal aortic aneurysms. Ann Vasc Surg. 1991;5(6):491–499.

Wanhainen

Verzini

Van Herzeele

, et al Editor’s choice–European Society for Vascular Surgery (ESVS) 2019 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms. Eur J Vasc Endovasc Surg. 2019;57(1):8–93.

Chaikof

Dalman

Eskandari

, et al The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm. J Vasc Surg. 2018;67(1):2–77.e2.

Lederle

Kyriakides

Stroupe

, et al Open versus endovascular repair of abdominal aortic aneurysm. N Engl J Med. 2019;380(22):2126–2135.

De Bruin

Baas

Buth

, et al Long-term outcome of open or endovascular repair of abdominal aortic aneurysm. N Engl J Med. 2010;362(20):1881–1889.

Harris

Vallabhaneni

Desgranges

, et al Incidence and risk factors of late rupture, conversion, and death after endovascular repair of infrarenal aortic aneurysms: the EUROSTAR experience. J Vasc Surg. 2000;32(4):739–749.

van Marrewijk

Buth

Harris

, et al Significance of endoleaks after endovascular repair of abdominal aortic aneurysms: the EUROSTAR experience. J Vasc Surg. 2002;35(3):461–473.

Hobo

Buth

; EUROSTAR Collaborators. Secondary interventions following endovascular abdominal aortic aneurysm repair using current endografts. J Vasc Surg. 2006;43(5):896–902.

Stoecker

Glaser

JD.

Review of type III endoleaks. Semin Intervent Radiol. 2020;37(04):371–376.

10.

Chang

Rothenberg

Harris

, et al Midterm outcomes for 605 patients receiving Endologix AFX or AFX2 Endovascular AAA Systems in an integrated healthcare system. J Vasc Surg. 2021;73(3):856–866.

11.

Maleux

Poorteman

Laenen

, et al Incidence, etiology, and management of type III endoleak after endovascular aortic repair. J Vasc Surg. 2017;66(4):1056–1064.

12.

Fujimura

Ichihashi

Matsubara

, et al Type IIIb endoleak is not extremely rare and may be underdiagnosed after endovascular aneurysm repair. J Vasc Interv Radiol. 2019;30(9):1393–1399.

13.

Kwon

Dimuzio

Salvatore

, et al Incidence of stent graft failure from type IIIb endoleak in contemporary endovascular abdominal aortic aneurysm repair. J Vasc Surg. 2020;71(2):645–653.

14.

Lal

Zhou

, et al Predictors and outcomes of endoleaks in the Veterans Affairs Open Versus Endovascular Repair (OVER) Trial of Abdominal Aortic Aneurysms. J Vasc Surg. 2015;62(6):1394–1404.

15.

Lemmon

Motaganahalli

Chang

, et al Failure mode analysis of the Endologix endograft. J Vasc Surg. 2016;64(3):571–576.

16.

Health Care for Devices and Radiation. Update on Risk of Type III Endoleaks with Use of Endologix AFX Endovascular AAA Graft Systems: FDA Safety Communication [Internet]. Silver Spring, MD: FDA; 2020. https://www.fda.gov/news-events/fda-brief/fda-brief-fda-provides-new-information-risks-patients-endovascular-grafts-based-real-world-data. Accessed March 11, 2023.

17.

LEOPARD. Endologix. https://endologix.com/leopard/. Accessed November 28, 2020.

18.

Endologix. Multicenter, post-market study to assess outcomes of patients treated with the AFX system compared to other EVAR devices for endovascular abdominal aortic aneurysm repair: LEOPARD [Internet]. https://clinicaltrials.gov/ct2/show/NCT02407457. Reporto. NCT02407457. Published September 2020. Accessed October 7, 2020.

19.

Gennai

Andreoli

Saitta

, et al Two decades of abdominal aortic endovascular repair with the anatomical fixation at the aortic bifurcation in a large single-center experience. J Endovasc Ther. 2022;29(1):42–56.

20.

Hoshina

Suhara

Miyahara

, et al Midterm outcomes of AFX2 endografts used in combination with aortic cuffs. J Vasc Surg. 2023;77(2):424–431.

21.

Moll

Powell

Fraedrich

, et al Management of abdominal aortic aneurysms clinical practice guidelines of the European Society for Vascular Surgery. Eur J Vasc Endovasc Surg. 2011;41(suppl 1):S1–S58.

22.

Chaikof

Blankensteijn

Harris

, et al Reporting standards for endovascular aortic aneurysm repair. J Vasc Surg. 2002;35(5):1048–1060.

23.

White

May

, et al Endoleak as a complication of endoluminal grafting of abdominal aortic aneurysms: classification, incidence, diagnosis, and management. J Endovasc Surg. 1997;4(2):152–168.

24.

Aburahma

Campbell

Mousa

, et al Clinical outcomes for hostile versus favorable aortic neck anatomy in endovascular aortic aneurysm repair using modular devices. J Vasc Surg. 2011;54(1):13–21.

25.

Gennai

Andreoli

Leone

, et al Incidence, long term clinical outcomes, and risk factor analysis of type III endoleaks following endovascular repair of abdominal aortic aneurysm. Eur J Vasc Endovasc Sur. 2023;66(1):38–48. https://www.sciencedirect.com/science/article/pii/S1078588423002253. Accessed June 1, 2023.

26.

Prentice

Paxton

Harris

, et al Risk for surgical interventions following endovascular aneurysm repair with Endologix AFX or AFX2 Endovascular AAA Systems compared to other devices. J Vasc Surg. 2023;78(2):333–343.e4.

27.

Forsyth

Carlson

Martin

, et al Late type III endoleaks are common in early generation Endologix AFX stent grafts. J Vasc Surg. 2022;76(3):680–687.

28.

Welborn

III McDaniel

Johnson

, et al Clinical outcome of an extended proximal seal zone with the AFX endovascular aortic aneurysm system. J Vasc Surg. 2014;60(4):876–883; discussion 883–884.

29.

Skibba

Evans

Greenfield

, et al Management of late main-body aortic endograft component uncoupling and type IIIa endoleak encountered with the Endologix Powerlink and AFX platforms. J Vasc Surg. 2015;62(4):868–875.

30.

Kwolek

Ouriel

Stucky

, et al Five-year results of the LEOPARD trial of commercially available endografts. J Vasc Surg. 2023;78(2):324–332.

31.

Wanken

Anderson

Trooboff

, et al Comparison of Endologix endografts made with Strata fabric versus IntuiTrak and Duraply fabrics. J Vasc Surg. 2019;70(3):e44.

32.

Castelli

Pfund

Auza

, et al Predictors of type IIIa endoleak after endovascular aortic repair with anatomic fixation endografts. J Vasc Surg. 2022;75(5):1583–1590.

33.

Silingardi

Tasselli

Gennai

, et al Thoracic endograft for abdominal aortic aneurysms, an unusual application for severe neck angulation: case report and literature review. Vascular. 2010;18(2):102–105.

34.

Cooper

Salzler

Ryer

, et al The combined use of thoracic and abdominal aortic stent grafts for endovascular repair of wide neck abdominal aortic aneurysms in high risk patients. Ann Vasc Surg. 2021;77:350.e1–350.

35.

Silingardi

Coppi

Benassi

, et al Influence of type of fixation and other characteristics on outcome after endovascular repair of ruptured abdominal aortic aneurysms. Ann Vasc Surg. 2019;57:83–90.